<ul data-eligibleForWebStory="false"><li>Solence, a French health startup, has secured €1.6M in seed funding to assist women with Polycystic Ovary Syndrome (PCOS) through lifestyle changes.</li><li>PCOS affects up to 20% of women globally, yet 85% lack sufficient support. Solence aims to address gaps in PCOS care by offering a digital app with a twelve-week program based on research.</li><li>The company focuses on lifestyle interventions beyond medication, providing tools for symptom management and leveraging data insights for personalized care.</li><li>Solence plans to utilize the funding to enhance its app's functionality, expand its team, establish clinical partnerships, and improve distribution strategies to benefit millions of women worldwide.</li></ul>

French femtech Solence bags €1.6M to help women manage PCOS through lifestyle changes

Discover more